Case study - downstream processing of monoclonal antibodies produced in bioreactors

Biopharmaceutical downstream processing (DSP) refers to the recovery and purification of a molecule of interest from the host cells. In this follow up video of our "Introduction to Downstream processing for bioreactors", I go through this process for production of monoclonal antibodies (MAbs) in bioreactors. There are over 500 MAbs approved for therapeutic purposes and scale up of the technology will be necessary to meet future demands.